Does CRIZOTINIB Cause Non-small cell lung cancer? 178 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 178 reports of Non-small cell lung cancer have been filed in association with CRIZOTINIB (Xalkori). This represents 1.8% of all adverse event reports for CRIZOTINIB.
178
Reports of Non-small cell lung cancer with CRIZOTINIB
1.8%
of all CRIZOTINIB reports
97
Deaths
60
Hospitalizations
How Dangerous Is Non-small cell lung cancer From CRIZOTINIB?
Of the 178 reports, 97 (54.5%) resulted in death, 60 (33.7%) required hospitalization, and 29 (16.3%) were considered life-threatening.
Is Non-small cell lung cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CRIZOTINIB. However, 178 reports have been filed with the FAERS database.
What Other Side Effects Does CRIZOTINIB Cause?
Death (2,028)
Neoplasm progression (1,161)
Nausea (820)
Disease progression (677)
Diarrhoea (631)
Vomiting (600)
Fatigue (419)
Off label use (353)
Dyspnoea (352)
Visual impairment (315)
What Other Drugs Cause Non-small cell lung cancer?
SOTORASIB (483)
CARBOPLATIN (431)
BRIGATINIB (370)
NIVOLUMAB (366)
PACLITAXEL (275)
IPILIMUMAB (273)
PEMETREXED (234)
CERITINIB (183)
AMG-510 (134)
BEVACIZUMAB (118)
Which CRIZOTINIB Alternatives Have Lower Non-small cell lung cancer Risk?
CRIZOTINIB vs CROFELEMER
CRIZOTINIB vs CROMOLYN
CRIZOTINIB vs CROTALIDAE POLYVALENT IMMUNE FAB
CRIZOTINIB vs CUBICIN
CRIZOTINIB vs CUPRIC